Table 2.

V_H gene use in 2 genetic subgroups of patients with BCP-ALL

Patient no.	IGH V region	Preferred B-1 V region?
CRLF2 overexpression
360	IGHV3-74	+
365	IGHV3-23, IGHV3-49	+
379	IGHV3-74	+
400	IGHV3-33, IGHV3-30	+
552	IGHV1-3, IGHV3-11, IGHV3-33
569	IGHV4-39	+
715	IGHV2-70
802	IGHV4-34, IGHV3-30	+
833	IGHV4-39	+
839	IGHV3-71
841	IGHV3-41, IGHV2-5
873	IGHV4-61, IGHV3-66, IGHV1-69	+
887	IGHV3-74, IGHV2-70, IGHV1-69	+
903	IGHV1-8
948	IGHV3-30	+
957	IGHV1-46, IGHV3-13, IGHV4-30	+
961	IGHV3-74, IGHV3-13	+
1047	IGHV4-39, IGHV3-7, IGHV2-26	+
1060	IGHV4-59	+
1063	IGHV3-71, IGHV3-30	+
1089	IGHV3-22, IGHV3-13
1097	IGHV2-26	+
1101	IGHV3-9	+
ETV6-RUNX1 fusion
960	IGHV3-21
968	IGHV3-13
985	IGHV3-23, IGHV2-5	+
991	IGHV6-1
997	IGHV2-5, IGHV4-61
999	IGHV3-22
1000	IGHV3-15
1029	IGHV5-3
1034	IGHV1-2, IGHV1-2	+
1042	IGHV4-61, IGHV2-5, IGHV3-41
1052	IGHV3-7
1053	IGHV7-4,IGHV2-5, IGHV3-30	+
1054	IGHV1-2, IGHV2-5	+
1059	IGHV3-74	+
1061	IGHV3-53, IGHV1-69	+
1075	IGHV3-74	+
1081	IGHV3-13
1084	IGHV1-8
1115	IGHV1-69, IGHV4-55	+
1118	IGHV3-71, IGHV2-5
1120	IGHV3-11, IGHV4-59	+
1122	IGHV2-70, IGHV3-23	+
1133	IGHV3-33
1139	IGHV3-71, IGHV1-45
1147	IGHV3-13
1153	IGHV3-7
1162	IGHV2-5
1170	IGHV6-1